Climb Bio, Inc.
CLYM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$67.9M | −$82.0M | +17.2% |
| Net income | −$59.9M | −$73.9M | +19.0% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$16.9M | −$14.9M | −13.4% |
| Net income | −$14.6M | −$12.9M | −13.2% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Climb Bio's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was Climb Bio profitable in FY2025?
- No: net income was −$59.9M and operating income −$67.9M in FY2025.
- What was Climb Bio's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.